Bioelectronics Corp (BIEL)

[ssmmss]

They should also do the DD that we blew a golden opportunity. We could have sold $20M per Q, instead of $33K.

The transfer of our UK over-the-counter product sales to reimbursable prescription sales behind the pharmacy counter mandates that the customer obtain a prescription from their assigned physician. As a prescription product, ActiPatch is available for free to 80 to 90% of the population in all 14,000 pharmacies.